GVR reverse heat balls
Commercial- Indications
- Weight management, Obesity
Company intelligence / Profile preview
Zhirui Biology operates primarily as an investment/incubation arm under the larger umbrella of Chongqing Zhifei Biological Products Co., Ltd. It supports R&D and commercialization of innovative biological products—mainly vaccines—and has enabled the launch of over eleven commercialized products targeting major infectious diseases. Through its investments it has exposure to advanced modalities like mRNA vaccines and CAR-T therapies. Its parent company's COVID‑19 vaccine "Zifivax" received conditional approvals internationally. Invested portfolio companies have achieved clinical milestones such as Breakthrough Therapy Designation for a domestic CAR-T product.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhirui Biology.